Health outcomes of patients with chronic illnesses are commonly worse in people of lower socioeconomic status (SES).
We investigated psychosocial factors that may mediate the relationship between SES and measures of morbidity in women with systemic lupus erythematosus (SLE).
We collected information on SES. psychosocial factors. and health status in a cross sectional survey of 100 women with SLE.
SES was rated using the Hollingshead Two-Factor Index. a weighted average of years of formal education and occupational prestige (higher Hollingshead Index=lower SES).
Health status measures included the Health Assessment Questionnaire Disability Index (HAQ). the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR), the Systemic Lupus Activity Measure (SLAM). and the SLE Disease Activity Index (SLEDAI).
Potential mediators consisted of IX environmental, medical care. social, psychological. and behavioral factors.
Patients with higher Hollingshead Indexes (lower SES) had more functional disability as measured by the HAQ (r=0.22 ; p=0.03) and more cumulative organ damage as measured by the SLICC/ACR Damage Index (r=0.19 ; p=0.06).
SES was not related to either the SLAM or SLEDAI.
Significant univariate associations were present between the Hollingshead Index and 10 potential mediating variables : household crowding. insurance status, organizational barriers to medical care. (...)
Mots-clés Pascal : Lupus érythémateux, Disséminé, Femelle, Health Assessment Questionnaire Stanford, Evaluation, Pronostic, Analyse corrélation, Niveau vie, Symptomatologie, Epidémiologie, Morbidité, Homme, Peau pathologie, Tissu conjonctif pathologie, Maladie système, Maladie autoimmune, Immunopathologie, Facteur psychosocial
Mots-clés Pascal anglais : Lupus erythematosus, Disseminated, Female, Health Assessment Questionnaire Stanford, Evaluation, Prognosis, Correlation analysis, Standard of living, Symptomatology, Epidemiology, Morbidity, Human, Skin disease, Connective tissue disease, Systemic disease, Autoimmune disease, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0433872
Code Inist : 002B07. Création : 25/01/1999.